What the August 27 Wholesaler Deadline Means for Your Pharmacy With the August 27 DSCSA wholesaler deadline now in effect,...
What the August 27 Wholesaler Deadline Means for Your Pharmacy With the August 27 DSCSA wholesaler deadline now in effect,...
On July 31, 2025, HRSA issued its highly anticipated guidance for a limited 340B rebate model pilot program set to...
When implemented strategically, referral capture can generate meaningful savings for 340B covered entities—savings that translate into expanded access to care...
In today’s complex and competitive healthcare landscape, communication is no longer just a support function—it’s a strategic asset. For small...
As the landscape of 340B program compliance continues to evolve, staying ahead of reimbursement challenges and legislative shifts is crucial...
The 340B Drug Pricing Program, while enabling eligible healthcare organizations to purchase medications at significantly reduced prices, has faced ongoing...
In this white paper, we’ll explore how Pharmacy Benefit Managers (PBMs) can leverage flexibility, innovation, and strategic partnerships to transform...
The Pharmacy Benefit Management (PBM) industry is on a trajectory of remarkable growth, with projections indicating global revenues will reach...
Maintaining a successful 340B program demands attentiveness and continued optimization. In this white paper, Draffin Tucker’s Brittany Edwards delves into...
In this white paper, 340B industry expert, Jason Prokopik of Blue & Co., provides a comprehensive exploration of the complexities inherent...
Interested in a deeper understanding of NADAC pricing as it relates to the drug pricing landscape? This paper provides a...
Kristin Fox-Smith, Managing Director Visante The 340B Drug Pricing Program has been instrumental in ensuring affordable prescription medications for healthcare...